Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | butyrylcholinesterase | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Brugia malayi | Carboxylesterase family protein | butyrylcholinesterase | 602 aa | 546 aa | 30.2 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | hypothetical protein | 0.0082 | 0.8825 | 1 |
Brugia malayi | Disco-interacting protein 2 homolog | 0.0041 | 0.3111 | 0.3525 |
Echinococcus granulosus | DNA methyltransferase 2, putative | 0.0021 | 0.0306 | 0.0347 |
Echinococcus granulosus | disco interacting protein 2 | 0.0041 | 0.3111 | 0.3525 |
Echinococcus multilocularis | acetylcholinesterase | 0.0082 | 0.8825 | 1 |
Plasmodium vivax | DNA (cytosine-5)-methyltransferase, putative | 0.0021 | 0.0306 | 1 |
Schistosoma mansoni | cpg binding protein | 0.0036 | 0.2362 | 0.2676 |
Echinococcus granulosus | cpg binding protein | 0.0036 | 0.2362 | 0.2676 |
Wolbachia endosymbiont of Brugia malayi | exonuclease III | 0.0019 | 0 | 0.5 |
Trypanosoma cruzi | apurinic/apyrimidinic endonuclease | 0.0019 | 0 | 0.5 |
Loa Loa (eye worm) | CXXC zinc finger family protein | 0.0036 | 0.2362 | 0.2676 |
Leishmania major | modification methylase-like protein | 0.0021 | 0.0306 | 1 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0046 | 0.3788 | 0.4293 |
Toxoplasma gondii | hypothetical protein | 0.009 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0082 | 0.8825 | 1 |
Mycobacterium tuberculosis | Probable exodeoxyribonuclease III protein XthA (exonuclease III) (EXO III) (AP endonuclease VI) | 0.0019 | 0 | 0.5 |
Echinococcus multilocularis | cpg binding protein | 0.0036 | 0.2362 | 0.2676 |
Echinococcus multilocularis | acetylcholinesterase | 0.0082 | 0.8825 | 1 |
Trypanosoma cruzi | apurinic/apyrimidinic endonuclease, putative | 0.0019 | 0 | 0.5 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0046 | 0.3788 | 0.4293 |
Echinococcus multilocularis | carboxylesterase 5A | 0.0082 | 0.8825 | 1 |
Trichomonas vaginalis | ap endonuclease, putative | 0.0019 | 0 | 0.5 |
Treponema pallidum | exodeoxyribonuclease (exoA) | 0.0019 | 0 | 0.5 |
Brugia malayi | GTP-binding regulatory protein Gs alpha-S chain, putative | 0.0046 | 0.3788 | 0.4293 |
Schistosoma mansoni | cpg binding protein | 0.0036 | 0.2362 | 0.2676 |
Schistosoma mansoni | DNA (cytosine-5)-methyltransferase | 0.0021 | 0.0306 | 0.0347 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0046 | 0.3788 | 0.4293 |
Schistosoma mansoni | disco-interacting protein 2 (dip2) | 0.0041 | 0.3111 | 0.3525 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0046 | 0.3788 | 0.4293 |
Toxoplasma gondii | C-5 cytosine-specific DNA methylase superfamily protein | 0.0021 | 0.0306 | 0.0306 |
Schistosoma mansoni | family S9 non-peptidase homologue (S09 family) | 0.0082 | 0.8825 | 1 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0046 | 0.3788 | 0.4293 |
Brugia malayi | Carboxylesterase family protein | 0.0082 | 0.8825 | 1 |
Onchocerca volvulus | 0.0041 | 0.3111 | 1 | |
Trypanosoma brucei | cytosine-specific DNA methylase, putative | 0.0021 | 0.0306 | 1 |
Giardia lamblia | Endonuclease/Exonuclease/phosphatase | 0.0019 | 0 | 0.5 |
Echinococcus granulosus | acetylcholinesterase | 0.0082 | 0.8825 | 1 |
Echinococcus multilocularis | DNA methyltransferase 2, putative | 0.0021 | 0.0306 | 0.0347 |
Schistosoma mansoni | cpg binding protein | 0.0036 | 0.2362 | 0.2676 |
Loa Loa (eye worm) | GTP-binding regulatory protein Gs alpha-S chain | 0.0046 | 0.3788 | 0.4293 |
Loa Loa (eye worm) | acetylcholinesterase 1 | 0.0082 | 0.8825 | 1 |
Echinococcus multilocularis | disco interacting protein 2 | 0.0041 | 0.3111 | 0.3525 |
Loa Loa (eye worm) | hypothetical protein | 0.0041 | 0.3111 | 0.3525 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0046 | 0.3788 | 0.4293 |
Echinococcus granulosus | carboxylesterase 5A | 0.0082 | 0.8825 | 1 |
Echinococcus granulosus | acetylcholinesterase | 0.0082 | 0.8825 | 1 |
Loa Loa (eye worm) | carboxylesterase | 0.0082 | 0.8825 | 1 |
Entamoeba histolytica | DNA (cytosine-5)-methyltransferase, putative | 0.0021 | 0.0306 | 1 |
Plasmodium falciparum | DNA (cytosine-5)-methyltransferase | 0.0021 | 0.0306 | 0.0306 |
Brugia malayi | CXXC zinc finger family protein | 0.0036 | 0.2362 | 0.2676 |
Trichomonas vaginalis | ap endonuclease, putative | 0.0019 | 0 | 0.5 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0046 | 0.3788 | 0.4293 |
Mycobacterium ulcerans | exodeoxyribonuclease III protein XthA | 0.0019 | 0 | 0.5 |
Brugia malayi | Carboxylesterase family protein | 0.0082 | 0.8825 | 1 |
Toxoplasma gondii | DNA methyltransferase 2, putative | 0.0021 | 0.0306 | 0.0306 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
EC50 (functional) | = 0.15 uM | Anti-HIV-1 activity tested in human lymphocytic CEM cells | ChEMBL. | 15139762 |
EC50 (functional) | = 0.15 uM | Anti-HIV-1 activity tested in human lymphocytic CEM cells | ChEMBL. | 15139762 |
IC50 (binding) | = 2.8 uM | Inhibitory activity towards human butrylcholinesterase | ChEMBL. | 15139762 |
IC50 (binding) | = 2.8 uM | Inhibitory activity towards human butrylcholinesterase | ChEMBL. | 15139762 |
IC50 (binding) | > 50 uM | Inhibitory activity towards Electrophorus electricus acetylcholinesterase | ChEMBL. | 15139762 |
IC50 (binding) | > 50 uM | Inhibitory activity towards Electrophorus electricus acetylcholinesterase | ChEMBL. | 15139762 |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Homo sapiens | ChEMBL23 | 15139762 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.